Kyn Therapeutics' Series A Round

Kyn Therapeutics raised a round of funding on December 14, 2017.

Kyn Therapeutics is a biotechnology company advancing new immunometabolic therapies for cancer.…

Articles about Kyn Therapeutics' Series A Round: